Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of COP 566.95 trillion. The enterprise value is 747.95 trillion.

Market Cap	566.95T
Enterprise Value	747.95T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.51%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.75 and the forward PE ratio is 8.75.

PE Ratio	14.75
Forward PE	8.75
PS Ratio	2.31
PB Ratio	1.56
P/TBV Ratio	n/a
P/FCF Ratio	13.98
P/OCF Ratio	11.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 18.44.

EV / Earnings	19.46
EV / Sales	3.11
EV / EBITDA	7.62
EV / EBIT	10.98
EV / FCF	18.44

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	3.03B
Profits Per Employee	474.44M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-2,678.21B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.67%
50-Day Moving Average	96,359.20
200-Day Moving Average	99,512.90
Relative Strength Index (RSI)	62.64
Average Volume (20 Days)	5,267

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.92

Income Statement

In the last 12 months, Pfizer had revenue of COP 245.48 trillion and earned 38.43 trillion in profits. Earnings per share was 6,749.27.

Revenue	245.48T
Gross Profit	183.64T
Operating Income	69.50T
Pretax Income	35.79T
Net Income	38.43T
EBITDA	95.63T
EBIT	69.50T
Earnings Per Share (EPS)	6,749.27

Full Income Statement

Balance Sheet

The company has 58.59 trillion in cash and 242.17 trillion in debt, giving a net cash position of -183,572.93 billion.

Cash & Cash Equivalents	58.59T
Total Debt	242.17T
Net Cash	-183,572.93B
Net Cash Per Share	n/a
Equity (Book Value)	363.99T
Book Value Per Share	63,811.70
Working Capital	40.38T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 51.13 trillion and capital expenditures -10,560.37 billion, giving a free cash flow of 40.57 trillion.

Operating Cash Flow	51.13T
Capital Expenditures	-10,560.37B
Free Cash Flow	40.57T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 7,033.98, which amounts to a dividend yield of 7.30%.

Dividend Per Share	7,033.98
Dividend Yield	7.30%
Dividend Growth (YoY)	3.25%
Years of Dividend Growth	n/a
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	7.12%
Earnings Yield	6.78%
FCF Yield	7.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7